Navigation Links
CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
Date:10/1/2007

. Legislative initiatives in Texas, California, North Carolina, Minnesota and other states have indicated rapidly growing interest in the benefits of increased provider reimbursement automation. These efforts, while initially focused on ebill transmission, lay the groundwork for other innovations that will further improve the cost effectiveness of healthcare delivery and reimbursement.

This fall CorVel plans to introduce further expansions to its CareMC healthcare transaction processing portal. These changes will continue the Company's strategic initiatives focused upon the integration of healthcare reimbursement and patient management activities. CareMC provides a central repository for electronic medical records and allows various constituencies role-based access to information on an "as appropriate" basis. The expansion of the CorCare network and new clearinghouse capabilities further enhance the capabilities of CareMC.

About CorVel

CorVel Corporation (http://www.corvel.com/) is a national provider of leading-edge services and solutions in the field of managed healthcare. CorVel specializes in applying information technology and e-commerce applications to improve healthcare management in the workers' compensation, group health, auto and disability management insurance markets. The Company provides networks of preferred providers, case management, utilization management, independent medical evaluations and medical bill review to more than 1,500 clients nationwide. Leveraging its commitment to flexibility and personal service, CorVel delivers custom solutions for employers, insurers, third party administrators and government entities.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements
'/>"/>

SOURCE CorVel Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Medical College receives $377K to study brain disease
11. Barriers will not stop convergence of medical technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...c. (NYSE: CRY ),a biomaterials, medical device an...it is scheduled to participate in the 19th Annual ... Hotel in New York City on Tuesday,November 27, 20...Life, Inc. will deliver,the Company,s presentation...fe,s live presentation may be accessed through its...
...re/ - Cytochroma Inc. announced today,that it has ... CTAP101,Capsules, the Company,s product candidate...hronic kidney disease (CKD). This Phase I/II clin...ed to establish the pharmacokinetic profile and sa...D insufficiency. The product,s,pharmacokinetic pro...
... Third quarter Consolidated Net Income NIS 178 Mil...Quarter 2006 Results Adversely Affected by,Norther...raft Prospectus for the Issue of,Debentures Primar...tures,Were Rated AA Stable by Maalot, a Standard a...ORL) ("Oil Refineries" or the "Company"),announced...
Other Biology Technology:CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York 2Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 3Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 4Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 5Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 6Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 7Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 8Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 9Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 10Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 11
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
Breaking Biology News(10 mins):A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3New research suggests how low doses of radiation can cause heart disease and stroke 59969 1New research suggests how low doses of radiation can cause heart disease and stroke 59969 2Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 1Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...eath among American men. It is estimated ...se during his lifetime. However, promising new tre...this threatening disease. , One of the most innova...oscopic prostatectomy (removal of the prostate). T...rently one of only a handful of fac...
... vitro fertilization offers couples the best chanc...potentially cause doctors to misdiagnose a small f... say. , Citing concerns about the accuracy of pre...actitioners use to pick the healthiest embryos dur...dure. Their work, described during a recent meetin...
...stem of adult mice appear to play a role in the br... olfactory neurons are especially sensitive to nov...new odors. This level of flexibility suggests tha... adapt to and integrate into other regions of the ...st to injury or disease. The report from research...
Other Biology News:Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 2Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 3Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3Neurons generated in the adult brain learn to respond to novel stimuli 2
...Microarray is specifically designed for location a...ins by pairing chromatin immunoprecipitation (ChIP...robust hybridization and reliable binding data wit...tives. In addition, Agilent provides flexibility b...
...ore user-friendliness and absolute reliability uni...ion of the Mastercycler ep system. In the past few...ynamically. The same applies to the capabilities r...echnological advances, the challenges of tomorrow ...
...s-based research with S. aureus, Sigma-Genosys has...at contains PCR primers to amplify all open readin...rimer pairs are included to amplify ORFs that are ...eus. The ORFmer set contains primers to amplify al...
...Handler is a high-capacity, plug-and-play bench to...ers, readers and liquid handling systems together ...ibility and intuitive and powerful software. Wheth...nking several modules together to complete a robot...
Biology Products: